Interplay between Tetanus, Diphtheria, Acellular Pertussis Vaccination in Pregnancy and Infant Pneumococcal

Eline Van den Bosch1, Helene Vermeulen2, Esra Ekinci1

  • 1Centre for the Evaluation of Vaccination, University of Antwerp, Wilrijk, Belgium.

PubMed

Insights

Maternal Tetanus, Diphtheria and acellular Pertussis (Tdap) vaccination during pregnancy was linked to higher pneumococcal vaccine-related serotype carriage in infants. Further research is needed to understand the clinical significance of this finding.

Area of Science:

  • Immunology
  • Vaccinology
  • Pediatric Infectious Diseases

Background:

  • Tetanus, Diphtheria and acellular Pertussis (Tdap) vaccination in pregnancy may impact infant immune responses to pneumococcal conjugate vaccines (PCVs).
  • The effect of maternal Tdap vaccination on infant nasopharyngeal carriage of pneumococcal vaccine serotypes is not well understood.

Purpose of the Study:

  • To investigate the association between maternal Tdap vaccination during pregnancy and pneumococcal vaccine-related serotype carriage in infants.
  • To analyze the impact of different pneumococcal conjugate vaccine schedules on serotype carriage.

Main Methods:

  • Collection of 3,298 nasopharyngeal swabs from infants aged 6-30 months in Belgium (2018-2022).
  • Assessment of Streptococcus pneumoniae carriage and serotyping using culture-based (Quellung reaction) and molecular methods (qPCR).
  • Logistic generalized estimating equation models used to evaluate the association between maternal Tdap vaccination and infant pneumococcal serotype carriage.

Main Results:

  • Infants born to mothers vaccinated with Tdap during pregnancy exhibited significantly higher PCV13-related serotype carriage.
  • Infants receiving PCV10 or mixed PCV10/PCV13 schedules showed increased PCV13-related serotype carriage compared to PCV13-only recipients.
  • A significant increase in carriage of serotype 6C was observed in infants of Tdap-vaccinated mothers; no difference in non-vaccine serotype carriage was found.

Conclusions:

  • Maternal Tdap vaccination during pregnancy is associated with elevated pneumococcal vaccine-related serotype carriage in infants.
  • The clinical implications of this increased carriage require further investigation.
  • Future studies should correlate vaccine serotype carriage with antibody levels to guide maternal and infant vaccination strategies.
Abstract

Related Concept Videos

Development of Immunocompetence01:22

Development of Immunocompetence

The initiation of cell-mediated immunity can be observed as early as the third month of fetal growth, with active antibody-mediated immunity following approximately one month later.
The initial cells that migrate from the fetal thymus settle within the skin and epithelial tissues lining the mouth, digestive tract, and in females, the uterus and vagina. These cells, including skin-based dendritic cells, serve as antigen-presenting cells, playing a key role in T cell activation.
Subsequent T...
448
Vaccinations01:51

Vaccinations

Overview
45.3K
Transcytosis of IgG01:15

Transcytosis of IgG

Transcytosis is the process in which molecules are internalized by endocytosis, transported across the cell, and released through exocytosis from the opposite end of the cell. Molecules such as insulin, immunoglobulins, and certain nutrients are transferred through the recycling endosomes by recycling and transcytosis.
IgG molecules from a mother undergo transcytosis starting around 13 weeks of gestation. The amount of IgG transferred and entering the fetal blood circulation increases with...
2.9K
Probability Laws01:49

Probability Laws

Overview
41.7K
Pneumonia I: Introduction01:30

Pneumonia I: Introduction

Pneumonia is an acute respiratory infection that targets the lungs, specifically the alveoli. These tiny air sacs, essential for oxygen exchange, become engorged with pus and fluid, severely hindering breathing, decreasing oxygen absorption, and causing significant pain and discomfort during respiration.
Risk Factors
Various factors influence the likelihood of developing pneumonia. Age plays a crucial role, with infants, children under two, and individuals over 65 at increased risk due to their...
326
Teratogenicity01:07

Teratogenicity

The ability of a drug to produce structural deformations and functional abnormalities in the developing embryo or the fetus is called teratogenicity, and the drug producing this effect is known as a teratogen. Teratogenic effects include stillbirth, miscarriage, intrauterine growth restriction, and neurocognitive delay. A teratogen may affect the embryo at different stages of development, which is important in determining the type and extent of the damage. During blastocyst formation, the early...
2.7K